galcanezumab   Click here for help

GtoPdb Ligand ID: 8967

Synonyms: clone III | Emgality® | galcanezumab-gnlm | LY-2951742 | LY2951742
Approved drug Immunopharmacology Ligand
galcanezumab is an approved drug (FDA (2018))
Compound class: Antibody
Comment: Galcanezumab (LY2951742) is a monoclonal antibody targeting calcitonin A and B (CALCA a.k.a. α-CGRP and CALCB a.k.a. β-CGRP respectively), whose anti-migraine and analgesic actions can be applied clinically.
Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record. Protein BLAST analysis reveals 100% matches with peptides claimed in patent WO2007076336 [1].
Classification Click here for help
Compound class Antibody
Approved drug? Yes (FDA (2018))
International Nonproprietary Names Click here for help
INN number INN
10277 galcanezumab
Synonyms Click here for help
clone III | Emgality® | galcanezumab-gnlm | LY-2951742 | LY2951742
Database Links Click here for help
Specialist databases
IMGT/mAb-DB 609
Other databases
GtoPdb PubChem SID 310264747
Search PubMed clinical trials galcanezumab
Search PubMed titles galcanezumab
Search PubMed titles/abstracts galcanezumab